Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

RUTHERFORD, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today that David S. Hirsh, MD, has joined the Company’s clinical advisory team as Medical Director – Cardiology, providing strategic leadership for clinical and educational initiatives for the Continuous Blood Glucose Monitor (CBGM).

Read more at globenewswire.com